TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
RexCell Tissue & Airlaid AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
113,879
|
131,523
|
117,295 |
| Financial expenses |
70
|
74
|
45 |
| Earnings before taxes |
25,754
|
37,878
|
21,430 |
| EBITDA |
26,903
|
39,342
|
24,034 |
| Total assets |
53,860
|
54,211
|
60,290 |
| Current assets |
27,434
|
29,356
|
35,978 |
| Current liabilities |
21,023
|
20,347
|
25,552 |
| Equity capital |
27,320
|
28,129
|
28,891 |
| - share capital |
104
|
108
|
108 |
| Employees (average) |
196
|
200
|
194 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
50.7%
|
51.9%
|
47.9% |
| Turnover per employee |
581
|
658
|
605 |
| Profit as a percentage of turnover |
22.6%
|
28.8%
|
18.3% |
| Return on assets (ROA) |
47.9%
|
70.0%
|
35.6% |
| Current ratio |
130.5%
|
144.3%
|
140.8% |
| Return on equity (ROE) |
94.3%
|
134.7%
|
74.2% |
| Change turnover |
-13,173
|
13,887
|
42,190 |
| Change turnover % |
-10%
|
12%
|
56% |
| Chg. No. of employees |
-4
|
6
|
4 |
| Chg. No. of employees % |
-2%
|
3%
|
2% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.